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Five years on from Godlee and Chalmers’ advocacy of greater
patient information to improve access to clinical trials,1we have
conducted research showing that engaging clinicians with local
research and trial information is as critical to enabling
participation as are public engagement and information
provision.
Our study explored the perceptions, motivations, and barriers
to trial participation among 1101 adult members of the public
and among 26 consultants, primary care physicians, and nurses
across southern England.
Some 90% of public respondents agreed that NHS supported
research was important, and 47% were likely to take part in
trials if asked, but only 10% had ever participated. Importantly,
respondents said that they would be more likely to take part if
their ownNHS clinicians were explaining the research; however,
research was discussed in only 5% of consultations in the
previous 12 months, and only 15% of respondents could recall
discussing trials with a clinician at any time.
Primary care physicians and hospital consultants perceive
themselves and peers either as “researchers”—an academically
orientated minority—or as “practitioners” focused on care
provision.While the “practitioners” were positive about research
and were happy to refer patients to trial, they lacked accessible
and reliable local information needed to do so.
Time and workload pressures were key barriers to discussing
research with patients, in terms of finding and assessing trial
information and of building discussion into consultations, while
the perceived bureaucratic burdens of research governance
limited people’s pursuit of research.
The finding that 95% of clinicians are not doing so, when they
are inherently trusted to explain trial options by a clearly willing
public, is critical if we are to achieve increased engagement
with research. It is clear that further targeting of resources
towards clinician engagement is needed, alongside management
and education interventions to make communication about trials
a routine part of all NHS consultations.
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